Monday, June 29, 2026

After U.S. Hits Iran, North Korea Boosts Its Own Nuclear Plans

North Korea is likely to enhance its nuclear capabilities in response to U.S. airstrikes on Iran, fearing similar actions against itself.

Trump’s 15%→25% Tariff Threat Puts Korea’s “U.S. Investment” Special Act in the Spotlight: What Happens Next?

South Korea's Minister Kim plans to visit the U.S. to address potential tariff increases announced by President Trump on various products.

North Korea Urges Workers to Break Free from Old Habits Ahead of Key Party Anniversary

North Korea's Workers' Party urges innovation and creativity among workers ahead of the 80th anniversary and 9th Party Congress.

Tag: diagnostics

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Samsung’s On-Device AI is Transforming Emergency Ultrasound Diagnostics in 2026

Samsung Medical Center is developing AI ultrasound tech for emergency care, enhancing diagnostics with real-time, on-device capabilities.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Dong-A Chammed Unveils Plans to Enter the In Vitro Diagnostic Blood Coagulation Testing Market

Dong-A Chammed will showcase innovative products at the 2026 Spring Symposium, aiming to expand into blood coagulation testing.

SCL Group Partners with Indonesian Hospital to Expand Into Southeast Asia

SCL Group partners with Indonesia's RSCM Hospital to expand Korean-style precision diagnostics in Southeast Asia, focusing on cancer screening and AI solutions.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.